SYK STRYKER CORP Insider Trading

SYK VP/CLO Robert S Fletcher sells 4,544 shares for $1.4M via scheduled 10b5-1 plan on 2026-05-28

Robert S Fletcher, VP and Chief Legal Officer of Stryker Corp, executed six separate sales totaling 4,544 shares for $1,394,409.11 on 2026-05-28, reducing his holdings by 30.0% from 15,126 to 10,582 shares. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2026-02-26, meaning it was scheduled rather than a discretionary decision. The blended average sale price of $306.87 compares to the current price of $305.09, placing the stock 24.6% below its 52-week high of $404.87. His prior trades at SYK showed mixed near-term outcomes (−4.1% at 30 days in August 2025 and +2.9% at 30 days in May 2024), providing no clear directional signal about this filing's timing.

Ronda E Stryker (Director) sold 310,000 shares for $96.8M across 6 transactions on 2026-05-26; stock down 20.8% in 90 days.

Ronda E Stryker executed six separate sales totaling 310,000 shares for $96,792,668.92, reducing her holdings from 2,910,815 shares to 2,600,815 shares (-10.6%). The sales were priced between $310.77 and $315.11 with a blended average of $312.23. Over her cross-ticker history, this insider's 20 prior sells have produced an average 90-day return of -17.0% with a 90.00% well-timed rate; at SYK specifically, all 5 prior sales executed on 2026-02-05 resulted in negative 90-day returns ranging from -19.1% to -20.3%. The current stock price of $305.94 is down 24.4% from its 52-week high of $404.87 and down 20.8% over the past 90 days. This pattern of consistent pre-decline selling, when considered against the subsequent price deterioration and the company's elevated P/E of 35.17, reflects a track record of transaction timing aligned with subsequent weakness.

VP Chief HR Officer Kathryn Fink sold net 3,500 shares, disposing of over $7.2M in total value across multiple transactions on May 8–11.

Kathryn Fink, VP and Chief HR Officer at Stryker, executed a series of transactions that netted a reduction of approximately 3,500 shares while generating over $7.2M in gross disposition value. The activity mixed equity grants (exercised shares and withheld tax), but the net effect is a net sale as she reduced her stake. The stock is trading well below its 52-week high and down notably over the past month and quarter, presenting a backdrop of price weakness. Fink's prior sales history at Stryker shows a conflicting pattern: all five prior sales were well-timed in the very near term as the stock declined in the following month, but poorly timed over a longer three-month horizon as the stock recovered. This latest sale occurs as the company remains solidly profitable with growing revenue, though valued at a relatively elevated multiple. Notably, Fink has no record of open-market purchases in the prior three-year window—this filing adds her 13th and 14th open-market sales, deepening a consistent pattern of net disposition.